Breaking News on Global Pharmaceutical Technology & Manufacturing

Loading...

Patheon launches CMC consultancy in face of restructuring plans

By Natalie Morrison+

15-May-2012

Patheon has launched a new consulting service designed to give emerging biotechs and pharmas a boost in their drug development efforts.

The provision, named Certified Consulting will see a team of 12 industry veterans providing their CMC (chemistry, manufacturing and controls) know-how for mid to late stage developers.

The CDMO (contract development and manufacturing organisation) says it will “draw the road map” for companies making decisions to drive molecules from discovery to development and scale-up.

Speaking to Outsourcing-Pharma at Interphex, Geoff Glass, executive VP of global sales and marketing said: “CMC – part of turning that molecule into something you and I can absorb as humans – is becoming more and more challenging.

“The industry has churned out more of these BCS (biopharmaceutical classification system) class II and IV compounds recently, and those products by their very nature require more complex techniques.”

He said Patheon spoke to the bods in charge at said companies, where there was a synonymous cry for guidance to prevent “making the mistakes a small company without the right knowledge set might make.”

Turn and face the change

The news comes in the midst of a structural overhaul for the firm , which will see many of its contract manufacturing operations in Swindon, UK, axed.

And it seems the Certified Consulting program falls in line with its efforts to “refocus” its business efforts on core operational programs.

In a statement the firm said that through the cuts, it would: “focus capital investments on its core business, and accelerate operational excellence programs to increase efficiency, meet customer needs, and improve its cost structure.”

Under the plans, 91 workers within the plant – which produces cephalosporin antibiotics and other sterile products – stand to loose their jobs by the end of the year, with a total of 400 employees hanging in the balance over the next three years.

Patheon expects to take a hit of around $55 to $65 million in payouts and redundancy packages.

The firm declined to comment when in-PharmaTechnologist asked if we should expect more service offerings similar to the Certified Consulting program, and more closures of manufacturing facilities.

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Missy Lowery

Marketing Manager for the Americas, Capsugel

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Cory Stevenson & Brandon Pence

Thermo Fisher Scientific

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

Eric Isberg

Global Product Manager, ATMI

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

John Giannone - incoming IPEC-Americas chairman

Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

Walter Dissinger

President , BASF nutrition and health

Optimism is returning to the pharma fine chemicals sector, says analyst

Optimism is returning to the pharma fine chemicals sector, says analyst

Jan Ramakers

Industry consultant, Jan Ramakers Fine Chemical Consulting Group

Capsugel expands liquid fill capsule capabilities

Keith Hutchison,

Senior VP of research and development (R&D) , Capsugel

New filtration tech boosts biomanufacturing yields, says Sartorius

New filtration tech boosts biomanufacturing yields, says Sartorius

Jens Meyer

Product manager for filtration technologies, Sartorius Stedim

Submit good REMS proposals for FDA brownie points, says RAPS author

Submit good REMS proposals for FDA brownie points, says RAPS author

Ed Tabor

VP of strategic drug development , Quintiles

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing